Mohammad Sayyah Selected Research

Anticonvulsants (Antiepileptic Drugs)

9/2019	Docosahexaenoic acid prevents resistance to antiepileptic drugs in two animal models of drug-resistant epilepsy.
10/2018	A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole.
10/2017	Hippocampal asymmetry: differences in the left and right hippocampus proteome in the rat model of temporal lobe epilepsy.
1/2017	In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures.
10/2015	Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
1/2015	Anticonvulsant effect of Cicer arietinum seed in animal models of epilepsy: introduction of an active molecule with novel chemical structure.
5/2012	Anticonvulsant Activity of Hydroalcoholic Extract and Aqueous Fraction of Ebenus stellata in Mice.
6/2011	Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients.
4/2007	Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors.
4/2005	Anticonvulsant activity of Heracleum persicum seed.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Sayyah Research Topics

Disease

30	Seizures (Absence Seizure) 10/2023 - 10/2002
13	Epilepsy (Aura) 01/2021 - 01/2005
7	Neuroinflammatory Diseases 10/2023 - 12/2003
6	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023 - 12/2015
5	Inflammation (Inflammations) 11/2022 - 06/2004
4	Rabies (Hydrophobia) 07/2022 - 01/2018
4	Infections 01/2022 - 01/2017
3	Toxoplasmosis 01/2021 - 10/2017
3	Alzheimer Disease (Alzheimer's Disease) 04/2019 - 10/2018
2	Cysts 01/2021 - 01/2017
2	Infarction (Infarctions) 11/2018 - 01/2018
2	Cognitive Dysfunction 11/2018 - 01/2018
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2017 - 01/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2013 - 10/2012
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Necrosis 01/2021
1	Drug Resistant Epilepsy 09/2019
1	Gliosis 01/2019
1	Wounds and Injuries (Trauma) 10/2018
1	Ischemia 01/2018
1	Temporal Lobe Epilepsy 10/2017
1	Memory Disorders (Memory Loss) 09/2017
1	Drug-Related Side Effects and Adverse Reactions 06/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013

Drug/Important Bio-Agent (IBA)

19	Pentylenetetrazole (Metrazol)IBA 10/2023 - 10/2002
12	Anticonvulsants (Antiepileptic Drugs)IBA 09/2019 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
6	LipopolysaccharidesIBA 12/2015 - 12/2003
5	salicylhydroxamic acid (SHAM)IBA 11/2022 - 03/2016
4	Glycoproteins (Glycoprotein)IBA 07/2022 - 01/2018
3	monophosphoryl lipid AIBA 11/2022 - 01/2018
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 01/2017
3	Docosahexaenoic AcidsIBA 09/2019 - 01/2017
3	Connexin 43 (Connexin43)IBA 01/2017 - 04/2010
2	CytokinesIBA 11/2022 - 01/2018
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 10/2015
2	Lamotrigine (Lamictal)FDA LinkGeneric 09/2019 - 10/2015
2	Amyloid beta-PeptidesIBA 04/2019 - 10/2018
2	Quinine (Quinson)FDA Link 11/2016 - 01/2013
2	Gap Junction delta-2 ProteinIBA 01/2013 - 04/2010
2	Messenger RNA (mRNA)IBA 12/2012 - 04/2010
1	CurcuminIBA 12/2023
1	Interleukin-4 (Interleukin 4)IBA 10/2023
1	Toll-Like Receptor 4IBA 11/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	CorticosteroneIBA 01/2022
1	Thymidine Monophosphate (TMP)IBA 01/2021
1	2-aminoethyl diphenylborinateIBA 01/2021
1	CalciumIBA 01/2021
1	CationsIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	JZL 184IBA 07/2020
1	Glycerol (Glycerine)FDA LinkGeneric 07/2020
1	EnzymesIBA 07/2020
1	CB2 Cannabinoid ReceptorIBA 07/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2020
1	CannabinoidsIBA 07/2020
1	Lipase (Acid Lipase)FDA Link 07/2020
1	iodopravadoline (AM 630)IBA 07/2020
1	AM 251 (AM251)IBA 07/2020
1	HU 308IBA 07/2020
1	ChloridesIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2019
1	Interferon-betaIBA 04/2019
1	Toll-Like Receptor 2IBA 12/2018
1	InterferonsIBA 12/2018
1	LigandsIBA 12/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018
1	Therapeutic UsesIBA 10/2018
1	GW 6471IBA 10/2018
1	N- palmitoyl- S- (2,3- bis(palmitoyloxy)propyl)cysteinyl- seryl- lysyl- lysyl- lysyl- lysineIBA 10/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2018
1	Lipid AIBA 01/2018
1	Saline SolutionIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 10/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 10/2017
1	ProteomeIBA 10/2017
1	Sulfamethoxazole FDA LinkGeneric 10/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2017
1	sodium bisulfide (NaHS)IBA 09/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Diazepam (Valium)FDA LinkGeneric 01/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 10/2015
1	ConnexinsIBA 01/2013
1	Connexin 30IBA 12/2012
1	Gap Junction beta-1 ProteinIBA 12/2012
1	Aripiprazole (Abilify)FDA Link 10/2012

Therapy/Procedure

3	Intraperitoneal Injections 11/2022 - 03/2016
3	Injections 11/2022 - 03/2016
3	Therapeutics 09/2019 - 12/2012
2	Traditional Medicine (Folk Remedies) 01/2011 - 06/2004
1	Intravenous Infusions 01/2021
1	Lasers (Laser) 01/2021
1	Polypharmacy 01/2021
1	Aftercare (After-Treatment) 10/2017
1	Drug Therapy (Chemotherapy) 06/2013